Asia-Pacific, in particular Japan, India and China, has been highlighted as an area of growing importance by Werum, with the company hoping the growing number of facilities and desire to raise quality will create opportunities in the region.

By increasing its presence in the region Werum is positioning itself to capitalise on the rise in demand for manufacturing execution systems (MES) that it expects to occur.

Hartmut Krome, chairman of the Werum executive board, said: "Many of our large multinational customers with operations in Asia-Pacific as well as local manufacturers will improve their manufacturing quality and drug safety in order to meet international standards.

"Our MES product PAS-X will be the key for such improvements. We expect future growth in the Asia-Pacific region to contribute a rapidly increasing share, with Japan and Singapore as the focal points of the business."

The two new offices will operate in conjunction with Werum’s partners in Japan, Singapore, Thailand, China and Australia.

What Werum offers

Werum’s PAS-X software has applications in fill and finish processes and the production and packaging of small molecules, biologics, vaccines and active pharmaceutical ingredients (API).

The company offers different versions of PAS-X to suit clients’ needs, from start up packages focused on a specific functionality to more comprehensive software.

Paperless production and archiving of process data is performed by the system, which operates in compliance with 21 CRF Part 11 rules for the handling of electronic records and signatures.